The Duodenal Switch (BPD‑DS) is the most powerful bariatric and metabolic procedure available. It combines sleeve gastrectomy with extensive intestinal bypass, producing the highest long‑term weight loss and strongest diabetes remission of any bariatric operation.

DS works through reduced stomach volume, powerful incretin stimulation, dramatic reduction in caloric absorption through intestinal bypass, bile acid pathway changes, and improved insulin sensitivity. The combination of restriction and malabsorption produces unmatched metabolic effect.

Benefits include the highest long‑term weight loss of any bariatric procedure, the strongest diabetes remission rates, significant improvement in hypertension, sleep apnea, fatty liver disease, and dyslipidemia, and durable metabolic control even in patients with BMI ≥ 50.

You may be a candidate for DS if you have: BMI ≥ 50; BMI ≥ 40 with severe metabolic disease; prior sleeve gastrectomy with inadequate weight loss or metabolic response; severe type 2 diabetes requiring maximum remission; or willingness to commit to lifelong nutritional monitoring and supplementation.

DS is performed laparoscopically. First, a sleeve gastrectomy is created. Then the duodenum is divided and the small intestine is rerouted to create a short common channel of 75–100 cm. Nutrients and bile mix only in this short segment, dramatically reducing caloric absorption.

Limb lengths are tailored to patient anatomy and metabolic needs. DS uses longer bypass limbs than SADI‑S, producing greater malabsorptive effect and higher nutritional risk.

DS carries higher nutritional risk than other procedures. Potential risks include protein malnutrition, vitamin deficiencies (A, D, E, K, B12, iron, calcium), diarrhea, loose stools, leak, stricture, and bile reflux. Lifelong supplementation and monitoring are mandatory.

Days 1–3: hydration, gentle movement, pain control. Week 1: clear to full liquids. Week 2: soft foods. Weeks 3–4: transition to normal routines. By 30 days: improved energy and early metabolic changes. Nutritional follow‑up begins immediately.

DS produces the highest long‑term weight loss and metabolic improvement of any bariatric procedure. Patients commit to lifelong vitamin supplementation, quarterly lab monitoring, and protein‑forward nutrition to maintain results and prevent deficiencies.

Dr. Nestor de la Cruz‑Muñoz is a nationally recognized bariatric and metabolic surgeon with outcomes that exceed national benchmarks. His high‑volume experience, advanced minimally invasive techniques, and long‑term metabolic support model ensure safe, effective, and compassionate care.

Most patients lose 36–40% of total body weight (TBWL) at 1 year. Long‑term success depends on protein‑forward nutrition, resistance training, consistent metabolic follow‑up, and mandatory lifelong supplementation.

DS produces the strongest metabolic response of any bariatric procedure: dramatic GLP‑1 and PYY elevation, profound improvement in insulin sensitivity, and remission of type 2 diabetes in over 90% of patients. It also produces the greatest improvement in dyslipidemia of any procedure.

DS is preferred for patients with BMI ≥ 50, severe metabolic disease, or prior sleeve with inadequate response requiring maximum metabolic effect.

Potential long‑term issues include protein malnutrition, vitamin deficiencies, diarrhea, and anastomotic complications. Mandatory lifelong supplementation, quarterly lab monitoring, protein‑first nutrition, and consistent metabolic follow‑up are essential.

DS includes a sleeve component, which may worsen reflux in some patients. Patients with severe pre‑existing GERD should be evaluated carefully. The malabsorptive component of DS may reduce reflux symptoms in others by altering bile acid circulation.

DS is an excellent revisional option for sleeve gastrectomy with inadequate weight loss or metabolic response. It may be performed as a staged procedure after sleeve gastrectomy. DS itself may be revised by adjusting limb lengths if nutritional complications arise.

Most insurers require documentation of BMI criteria, comorbidities, supervised weight‑loss attempts, and medical clearance. Our team handles verification and authorization.